Using transgenic mice, we have examined the expression pattern conferred by regions of genomic GAP-43 coupled to &galactosidase.
We demonstrate that gene constructions that include the GAP-43 5'-flanking region along with sufficient sequences of the first intron drive@-galactosidase (IacZ) expression to mimic in many regards the complex spatial and temporal pattern of endogenous GAP-43 expression. Transgene expression reaches peak levels during development, and persists at high levels in particular adult brain regions, such as the hippocampus and olfactory bulb. The inclusion of a stretch of the first intron in the construction is necessary to prevent expression outside of the nervous system, indicating that some of the cell specificity of GAP-43 expression is due to suppression of expression in inappropriate tissues. Injury caused by sciatic nerve crush causes reexpression of the transgene in adult sensory and motor neurons. This genomic region of GAP-43, therefore, includes elements responsive to neuronal growth signals that regulate both development and regeneration. [Key words: GAP-43, neuromodulin, transgenic mice, regeneration, development, intron] Prominent nerve cell growth occurs during developmental and regenerative axonogenesis.
More subtle and focal growth accompanies certain types of long-term memory consolidation (Bailey and Chen, 1988) . Orchestrated patterns of gene expression are likely to coordinate these types of nerve cell growth, but the molecular basis ofsuch genomic control remains unclear.
GAP-43 was first suggested as an underpinning of axonal growth by dint of its high level expression during development and regeneration (Skene and Willard, 198la, b) . With rare exceptions, it is expressed strictly in neurons. During development, GAP-43 is first expressed after neuroblasts have ceased mitosis, when they are extending their processes (Biffo et al., 1990) . For most neurons expression peaks in the perinatal period and then recedes. High-level expression persists in the adult in certain regions, such as the entorhinal cortex, the hippocam-pus, the olfactory bulb, and the association cortices. This has been linked speculatively to the continued plasticity of these structures in the adult (Benowitz et al., 1988; De la Monte et al., 1989) . Other work has suggested roles for this protein in long-term potentiation (Lovinger et al., 1985) as well as in transduction of signals at the growth cone and synapse (Alexander et al., 1987; De Graan et al., 1988; Dekker et al., 1989; Strittmatter et al., 1990) . GAP-43 is highly regulated at the level of gcnc expression. High GAP-43 levels, assessed by in situ hybridization or Northern blot, are present during development, in the adult regions where expression persists, and during regeneration (Neve et al., 1987; Rosenthal et al., 1987; Hoffman, 1989; Bendotti et al., 199 1; Fitzgerald et al., 199 1) , although it is not clear how much of this regulation is transcriptional.
In viva, transcriptional control of GAP-43, during both development and regeneration, has been documented by nuclear run-on assays (Basi et al., 1987) . In cell culture, glucocorticoid suppression of GAP-43 mRNA expression has been shown to be at the level of transcription, while induction by NGF appears to be posttranscriptional (Federoff et al., 1988; Perrone-Bizzozero et al., 1993) . Since growth regulation is a complex process, with multiple cell-autonomous and extrinsic controls best evaluated in the intact animal, we have begun the dissection of the regulatory regions of the GAP-43 gene in transgenic mice. Our results demonstrate that constructions including the 5'-flanking sequences and sufficient portions of the first intron largely mimic natural GAP-43 expression. Furthermore, this region of the GAP-43 gene also includes elements that enhance expression in injured nerves.
Materials and Methods

Plasmid
construction.
All cloning steps were carried out in the plasmid vector pSP72 (Promega). To facilitate the isolation of the constructions from the vector, Not1 and SIil restriction sites were introduced outside the XhoI and BglII sites that flank the polylinker. Constructions that included thefirstexon(lOE4,6El 1,6E0.2, 1.6El2, 1.6E4)weredesigned to splice to give polycistronic messages (Kozak, 1986b (Kozak, , 1987 . Analogous splicing constructions containing the bacterial chloramphenicol acetyl transferase gene have been tested in vitro (E. Grabczyk, A. Pack, and-M. C. Fishman, unpublished observations) . To achieve this, the bacterial la&gene cassette (BamH l/HindIII) was excised from pCH I IO (Pharmacia) and inserted into pSP72Not (BglII/HindIII).
Bacterial sequences in the 5' end of the IacZ cassette were then excised (HindIII/ KnnB and reulaced with an 88 base oair (bn) olinonucleotide: AGCTTkAGTGAC;TAAGTGAGTAAGT&CATTT&TTCTGTCACAA-~ --CTGTGTTTCACTTmACCTCCAAACAGACACCACCA TGGTAC that contained tandem translation stop signals in each reading frame and a favorable eukaryotic translation initiation site (Kozak, 1986a) . All constructions that included portions of intron I also contained the splice acceptor sequence from the second exon of the GAP-43 gene (Grabczyk et al., 1990 ). This sequence is included in a 220 bp fragment (SstI/AvaII) of the GAP-43 gene that was excised from splicing construction precursor 72gavacat (Grabczyk, Pack, and Fishman, unpublished observations) and was cloned upstream of the 88 bp oligonucleotide (HindIII). This step regenerated the pSP72 polylinker from SstI to HindIII. Constructions IOE4, 6EI I, and 1.6El2 were obtained by inserting the genomic clones lORlX4, 6RlX10, and 1.5RlX12 (Grabczyk et al., 1990) upstream of the splice acceptor sequence in Sal1 of the polylinker. Construction 6E0.2 was made by deleting the intron sequence from NaeI 1+0.2 kilobase (kb)l to Sal1 (+ I I kb) from construction 6EI I. To obtain construction 1.6E4, a 5:6 kb SaII/SstI fragment was subcloned from the genomic clone 1.5RlXl2 (Grabczyk et al., 1990) and inserted upstream of the splice acceptor sequence (SalI/ SstI). For construction 1.6, a single base pair change introduced by oligonucleotide directed mutagenesis downstream of the GAP-43 ATG created an NcoI restriction site (Grabczyk, Pack, and Fishman, unpublished observations) . This new restriction site was used to obtain a I .6 kb SalI/NcoI fragment (-1.6 to + I). The fragment was subsequently fused to the NcoI site at the new IacZ ATG. Transgenic mice. To isolate the fusion gene for microinjections, the DNA was digested with Not1 or SfiI. After electrophoretic separation in 0.8% agarose, the appropriate fragment in gel was dissolved in saturated Na-perchlorate (1 hr at 37°C) and isolated in a glass filter (Gelman Sciences Inc., Ann Arbor, MI). Transgenic mice (from strain B6D2Fl/J; Jackson Laboratories, Bar Harbor, ME) were generated essentially as described in Hogan et al. (I 986) and as is standard in this laboratory (Baetscher et al., I99 1) . Briefly, purified DNA (l-2 &ml in 5 mM Tris, 0. I mM EDTA, pH 7.4) was microinjected into the male or female pronucleus of fertilized eggs (I 4-20 hr after fertilization). Subsequently. the eggs were incubated overnight at 37"C, 5% CO? in Ml6 medium (Hogan et al., 1986) . Eggs that had developed to the two-cell stage were reimplanted in 12 hr pseudopregnant foster mothers. The resultant animals are referred to as founders, or F0 generation. Tail biopsy-derived DNA was used for screening of the animals.
Histochemistry. P-Galactosidase histochemistry was performed according to Turner and Cepko (I 987) . Embryos up to day 13.5 (El 3.5) were fixed by immersion in PFA (2% paraformaldehyde, 2 mM MgCI,, I .25 mM EDTA in 0. I M PIPES, pH 6.9) and stained for &aalactosidase activity as whole-mounts. Tissues of older embryos, and postnatal animals up to day 7 (P7), were fixed by immersion and cryostat sectioned prior to histochemistry. Animals older than P7 were perfused with phosphate-buffered saline (PBS, pH 7.4) followed by 2% PFA in deep anesthesia (0.04 ml of 2% Avertin per gram of body weight). Prior to sectioning, the tissue was cryoprotected in 30% sucrose (in PBS with 2 mM MgC&) for I2 hr. Before staining, the cryostat sections or wholemounts were rinsed for IO-50 min in PBS (with 2 mM MgCI) followed by PBS with 2 mM MgCl, and detergents (00.1% sodium desoxycholate, 0.02% NP40). Routinely, X-Gal staining was performed for 14-16 hr overnight at 37°C in 1 mg/ml 5-bromo-4-chloro-3-indolyl /3-o-galactopyranoside, 5 mM K,Fe(CN),, 5 mM K,Fe(CN), 3H,O, 2 mM MgCI,, 0.01% sodium desoxycholate, 0.02% NP40 in PBS.
Surgery. For regeneration studies, the animals (8 weeks and older) were anesthetized with 2% Avertin (0.02 ml/gm body weight). The left sciatic nerve was exposed after a small cut in the skin and underlying muscle tissue. Subsequently the nerve was crushed twice for I5 set with a small forceps. Muscles and skin were sutured and the animals were allowed to recover. At various times after the operation, the animals were anesthetized and perfusion fixed. Lumbar and posterior thoracic segments of the spinal column were dissected and processed for cryostat sectioning and X-Gal staining, as described above.
RNase protection. A probe corresponding to the spliced product of the GAP-43/&galactosidase fusion gene from 50 bases 5' of the GAP-43 ATG to 330 bases 3' was produced by polymerase chain reaction (PCR). A plasmid containina the GAP-43 cDNA that was digested with AvaII, which cuts 22 bp downstream ofthe GAP-43 first splice junction, a region shared with the /3-galactosidase construct precursor plasmid linearized with Sac1 (upstream of the splice acceptor). The two plasmids were mixed with two oligonucleotides, G-SOBam (CCCCGGATCCGA-GAGGAGGAAAGGAGAGAAGG) and b380Eco (CCCCGA-ATTCCCTCTTCGCTATTACGCCAG).
and PCR was nerformed to zip the pieces together. The products were digested with-B&H l/EcoRI and a 380 bp fragment was gel purified and subcloned into pSP72 from EcoRI to BamH I. The final clone GAP/b380 was sequenced to be sure that no point mutations were introduced.
Total cellular RNA was isolated from brain, skin, and liver ofnewbom transgenic and normal mice by CsCl ultracentrifugation after tissue disruption in guanidinium isothiocyanate. PolyA + RNA was isolated from 500 pg of total RNA with the PolyATtract kit (Promega). The probe was synthesized from the T7 promoter of clone GAP/b380 and RNase protections were performed as described previously (Grabczyk et al., 1990) .
Results
St-Flanking and intron regions are needed,for neuron-specific mpression
The GAP-43 gene is encoded in three exons, and has two long introns (Grabczyk et al., 1990) . RNase protection and primer extension indicate transcriptional initiation to be from several 5' sites, the most prominent at 52 bases from the initiation ATG (Grabczyk et al., 1990) . One report suggests predominant use of one site at about -460 (Nedevi et al., 1992) . The constructions used, as shown in Figure 1 , all included at least 1.6 kb 5' ofthe initiating ATG and therefore included all proposed major and minor start sites. Pilot experiments, with examination of F,, animals, revealed that 1.6 kb of 5'-flanking sequence does cause neuronal expression ofthe transgene, but that this genomic region is insufficient to restrict expression to neurons. As shown in Table 1 , constructs with 1.6 kb 5' of GAP-43 are expressed in many non-neuronal tissues. In fact, even up to 6 kb of 5'-flanking region is insufficient to prevent expression outside of the nervous system (Table 1) . Intron-exon splice junctions can enhance expression of some transgenes (Brinster et al., 1988; Choi et al., 1991; Palmiter et al., 1991) so F, animals were generated that bore 200 bases at the 5' and 3' end of intron 1 in addition to 6 kb of 5'-flanking sequence (constructs 6E0.2) but these animals also have widespread expression outside of the nervous system.
Clearly these genomic regions are insufficient to restrict expression to neurons. Analysis of the pattern within the brain itselfis complicated in F, animals because they may be chimeric. For that reason other series of transgenic animals were bred and maintained as lines. Preliminary experiments in tissue culture indicated that the first 4 kb of intron 1 is sufficient to confer a response to glucocorticoids (E. Grabczyk and M. C. Fishman, unpublished observations). Therefore, this region was included in several transgene constructs. Four separate lines of 1.6E4 (1.6 kb5land4kbofintron l)andtwooflOE4(10kbS'and4kb 
Cryostat sections were stained for /3-galactosidase activity for standard periods of time and staining intensity within the different tissues was estimated on the following scale: -, almost no positive cells; +, scattered positive cells; + +, a majority of cells weakly stained, or few cells strongly stained; + + +, almost all cells in a tissue moderately or strongly stained. Cc, cerebral cortex; Hip, hippocampus; Ob, olfactory bulb; Cer, cerebellum; DRG, dorsal root ganglia; Bn, bone (includes cartilage); Kid, kidney; LIV. hver. The skin labeling was evaluated in the region of the snout, and was completely restricted to the dermis in all lines labeled in the skin, except for line 5 16, where labeling was essentially restrlcted to the epidermis. of intron I) wet-c generated and offspring analyzed as shown in Table 1 and illustrated in Figure 2 .
In the perinatal period, these animals all express @-galactosidase in the brain. However, in all cases, they also express @-galactosidase outside of the nervous system. Examples of the patterns of non-neuronal expression in some of these lines are illustrated in Figure 2 , which shows low-power cross sections of a representative animal for each construct, done at the level of the kidney. As shown, animals containing transgene constructs that lack the region of intron from 4 to 11 kb show b-galactosidase activity outside of the nervous system (Fig. 2.4-D) . In all ofthese lines, there is expression in the nervous system, but this aspect was not pursued in detail in lines showing additional inappropriate non-neuronal expression.
Constructs with longer stretches of intron I more closely approximate the pattern of native GAP-43. The perinatal distribution of expression in five lines bearing two different constructions, with 1 1 kb and I2 kb of intron 1, respectively, is shown in Table I , and Figure 2 , E and F. There is no expression in any of the examined non-neuronal tissues in mice with these transgenes. Within the nervous system, expression is absent in fiber layers or fiber tracts of the brain, retina, and spinal cord, suggesting that glial cells do not express these transgenes.
There is some variability between the three 6El 1 lines, and between the two I .6E12 lines. As shown in Table 1 , several of these lines express the transgene only in subsets of predicted GAP-43+xpressing neuronal populations. However, expression is always restricted to neurons. The variability is due, in all likelihood, to the well-described chromosomal position effects upon transgene expression that has been observed for many transgenes (Al Shawi et al., 1990; Allen et al., 1990; Bonnerot et al., 1990; Tan, 1991; Weis et al., 1991) . It is also certainly conceivable that, as for the globin gene cluster (Grosveld et al., 1987; Reitman et al., 1990 ) additional elements, even tens of kilobases away, might enhance the overall level of expression, and insulate the transgene from position effects.
Occasionally a small population of non-neuronal cells transiently expresses these transgenes in the midfacial mesenchymal tissue between the two nares at embryonic or early postnatal stages. A similar observation has been described for fusion genes using the neuron-specific promoter of the dopamine @-hydroxylase gene (Kapur et al., 199 1) .
RNase protection assays were carried out in order to verify that transgene expression initiates within the GAP-43 upstream region, and that it is correctly spliced. The probe used, as shown in Figure 3A , corresponds to the predicted correctly spliced product from the transgene, and therefore should be fully protected (except for the flanking bacterial sequences, shown as the thin black line) only if transcription initiates within the GAP-43 promoter and is spliced accurately. Native GAP-43 transcription initiates from multiple sites (Grabczyk et al., 1990) and the 3' end of this probe corresponds to the most prominent and proximal of these start sites, effectively summing all transcripts from this and more 5' sites.
Expression was examined in line 150, a 6E1 1 line with neuron-specific expression, and in line 526, a 1.6E4 line with prominent neuronal and non-neuronal expression. Native GAP-43 is revealed by the 102 base protected fragment in all samples of brain RNA (lanes 3, 6, 9, 12) in Figure 3B , and is clearly expressed at a much higher level than is the transgene. The fully protected fragment of 380 bases is present using RNA from the brain of line 150 mice (Fig. 3B, lane 3) but not using skin or liver RNA from this line (lanes 4, 5). In contrast, in line 526, this fragment is protected using RNA from skin and liver (lanes 7, 8) in addition to that from the brain (lane 6). The data from RNase protection cannot be compared quantitatively to that of . . --. ically may be diluted by nonexpressing tissue when extracted for RNA. For example, for line 526, in RNase protection there are lower levels of the protected 380 base fragment in skin and liver than in brain; Table 1 shows that subpopulations of cells of these tissues expressed the transgene at levels nearly as high as cells of the brain. Figure 2 also shows the patchiness of &ga-lactosidase expression when expressed in many of the non-neuronal tissues.
I he pattern 01 transgemc expression resembles GAP-43
We examined line 150 (a 6Ell line, with 6 kb 5' and 11 kb of intron 1) in more detail because preliminary observations suggested that its expression resembled the pattern of GAP-43 expression. Relative levels ofp-galactosidase expression were carefully analyzed in several regions of the CNS and PNS, as shown in Table 2 . We examined these regions at several developmental stages. For this estimation, cryostat sections ofanimals ofline 150 (construction 6E I 1) were developed under identical conditions, and for identical times, and evaluated using the following expanded scale: -, almost no positive cells; x, less than half of the cells weakly stained (staining often in small vesicles); xx, majority ofcells weakly stained (staining in small vesicles); xxx, majority of cells moderately stained (staining in large dark blue vesicles) or almost all cells weakly stained; xxxx, almost all cells stained (staining in large dark blue vesicles); xxxxx, almost all cells strongly stained (cell bodies uniformly filled with light blue or dark blue precipitate); xxxxxx, almost all cells heavily stained (cell bodies filled with dark blue precipitate, proximal cellular processes stained). DG, dentate gyrus; n., nucleus; GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer.
During development, P-galactosidase labeling first becomes evident at E 10.5, as shown using whole-mount staining in Figure  4 . At this time there is substantial P-galactosidase staining in cranial ganglia, and in the ventral midbrain, brainstem, and anterior spinal cord. By E12.5 expression is more widespread, and includes all dorsal root ganglia (DRG), the entire rostrocaudal extent of the spinal cord, and ventral portions of the brain. In the cerebral cortex at E15.5, positive cells are mainly found adjacent to the olfactory bulb and hippocampal formation. By the day of birth, labeled cells are found throughout the cortex. Expression peaks at P7. At this stage virtually all cortical neurons express the transgene.
After P7, the intensity diminishes until adulthood. Restriction to subpopulations of neurons begins to become evident shortly after birth, for example, in the olfactory bulb, mostly to the mitral cells (Fig. 5A,B) , and in the retina to the ganglion cells, whereas in the DRG and sympathetics, staining still is uniform. The rate of decline of P-galactosidase expression in the cortex appears to be slower than that observed by Basi et al. (1987) for native GAP-43. This could be due to differences in regulation, or to a higher stability of the bacterial protein P-galactosidase in eukaryotic cells. In several regions of the nervous system, especially the brainstem and spinal cord, /3-galactosidase activity is expressed only during a brief temporal window (see Table 2 ), and in several others it persists in the adult. For example, in the adult olfactory bulb, considerable P-galactosidase activity continues to be associated with neurons of the mitral cell layer, as is native GAP-43 mRNA in the rat (De la Monte et al., 1989) .
The hippocampus is a region where there has been much focused interest concerning possible roles ofGAPin synaptic plasticity (Benowitz and Routtenberg, 1987) . The developmental regulation and spatial distribution of transgene expression within this region is shown in Figure 6 . As in neighboring cortical areas, the transgene shows highest expression about 1 week after birth (Fig. 6C) and reaches its adult level several weeks later. Within the adult hippocampus (Fig. 60) , CAl, CA2, CA3, and CA4 contain many robustly positive pyramidal cells, as do the neighboring entorhinal cortex and subicular complex, whereas the dentate contains only a few scattered positive neurons.
Regeneration enhances transgene expression
The expression of GAP-43 is induced in certain adult neurons during regeneration (Skene and Willard, 198 1 b; Van der Zee et al., 1989; Woolf et al., 1990) . Since the developmental profile suggests that growth-regulatory elements are included in these constructions, we evaluated the regeneration responsiveness of the gene in line 150. One sciatic nerve was crushed, and the DRG and spinal cord of lumbar and posterior thoracic regions of three operated animals were examined between 4 and 15 d later. In all of these animals, P-galactosidase expression increases markedly in the soma of the regenerating nerves. Within the spinal cord, the increase is restricted to a population of motor neurons that are located in the ventral horn of lumbar segments 1, 2, and 3 on the injured side (Fig. 7A) . In the DRG of lumbar segments 4 and 5 there is also an increase, but it is less dramatic in appearance because the basal level of expression is higher.
These experiments were also done with three animals of a transgenic line carrying the other neuron-specific construction (line 158; construction 1.6E 12). As in line 150, strong induction of P-galactosidase is evident in motor neurons of lumbar segments 1, 2, and 3 on the operated side (Fig. 7B) . As shown in Figure 7C , in these animals basal DRG expression is low, so that, as shown in Figure 70 , the regeneration-induced increase is clear.
Discussion
The combination of GAP-43 5'-flanking sequence with 11 kb of intron 1 is capable of conferring nervous system-specific expression upon P-galactosidase. The transgene becomes activated during embryogenesis at about the same time and within the same regions as does the endogenous GAP-43 gene (cf. Biffo et al., 1990 ) and diminishes after the peak time of neuronal growth. As is true for GAP-43, adult expression ofthe transgene continues in particular subpopulations of neurons. This suggests that the complex pattern of GAP-43 RNA expression is mediated by elements included within this region of the genome.
at least as the latter has been evaluated in the rat. For example, both the transgene and GAP-43 are expressed in CAI, CA2, and CA3, but, in the rat, CA3 contains relatively more GAP-43 than does CA1 (Meberg and Routtenberg, 199 l) , whereas the transgene is expressed at comparable levels in CA 1 and CA3. Some of the differences may be due to differences in stability and subcellular distribution between /3-galactosidase and GAPEven with line 150 there are some subtle differences between the pattern of transgene expression and that of GAP-43 RNA, constructions are expressed in neurons, it is likely that these 5'-flanking regions contain positive elements, with regard to neuronal expression. Transgene expression in non-neuronal tissue occurs with two different intron deletions, as well as with no intron at all, indicating that it is not an artifact due to new sequences conferred at junction sites within the construction. The inclusion of generic introns tends to increase the level of transgene expression in transgenic mice (Brinster et al., 1988; Choi et al., 199 1; Palmiter et al., 199 l) , but this alone is unlikely to explain the findings reported here because four of the constructions, even those without neuronal specificity, include large portions of the intron (including the splice donor and acceptor sites), and mice with an intronless construction do not show lower expression levels generally, but rather shift locales of expression. Therefore, it is likely that the intron sequence serves to suppress expression in non-neuronal tissues. Suppression as a means to restrict expression has been demonstrated in transgenie mice, for example, with the gene SCGlO (Wuenschell et al., 1990) .
side in the 5'-flanking region and do include some sequence similarities (Vandaele et al., 199 1) .
Although in many cases elements that cause tissue specificity appear to reside in the 5'-flanking region of a gene, a role also has been noted for cis-acting elements in the introns. For example, the Thy-1 gene has elements responsible for brain, thymus, kidney, and spleen expression, and all are separate and all Regulatory elements that drive neuron-specific expression in transgenic animals have been described for several genes, including those for the amyloid precursor protein (Wirak et al., 199 l) , neurofilament (Julien et al., 1987) Purkinje cell-specific protein 2 (Oberdick et al., 1990; Vandaele et al., 199 1) . olfactory marker protein (Danciger et al., 1989) neuron-specific enolase (Forss-Petter et al., 1990) rhodopsin (Lem et al., 1991; Zack et al., 199 l) , and dopamine P-hydroxylase (Mercer et al., 1991) . No specific sequences have been identified that cause neuronal expression, although the responsible elements described all re-43. In addition, there may be a distinction in GAP-43 distribution between mouse and rat. In fact, as opposed to the rat, in the mouse the levels of GAP-43 expression in CA1 and CA3 are comparable (P. J. Meberg and A. Routtenberg, personal communication) . It is also possible that the transgene is not regulated identically to native GAP-43 in all regards.
Regulation of transcription initiation is the most straightforward and most likely mechanism by which these elements could exert control. RNA stability can, at least in PC12 cells, play a role in regulation of GAP-43 levels (Perrone-Bizzozero et al., 1993) but is not likely to the primary determinant of neuronal specificity because all of the constructs that included intron, whether neuron specific or not, generated the same spliced product. We have not formally ruled out alternative splicing or transcriptional termination within the intron as contributing factors.
All of these transgene constructions include a minimum of 1.6 kb upstream of the initiating methionine, which is well 5' of all proposed initiation sites. Both primer extension and RNase protection agree that there are multiple sites of RNA initiation (Grabczyk et al., 1990) but an argument has been made for one ofthe longer transcripts, starting about 460 bp upstream ofthe ATG translation start site, being the principle one (Nedevi et al., 1992) . All of these transgenes cause expression in the nervous system, but even up to 10 kb of 5'-flanking sequence is insufficient to restrict expression to neurons in the absence of are downstream of transcription initiation, including the brainspecific element that is in the first intron (Vidal et al., 1990) .
The overall levels of transgene expression are much lower than that of endogenous GAP-43 and are subject to chromosomal position effects. This suggests that these constructions may lack a dominant regulatory region, as has been found for the globin gene family. A region roughly 50 kb upstream of the globin gene cluster is essential for position-independent expression of transgenes at a level per copy that approximates that of the endogenous gene (Grosveld et al., 1987; Reitman et al., 1990) . Hence, it is quite conceivable that other elements serve to increase the level of neuronal expression, in addition to those regions we have found to suppress it in non-neuronal cells. As noted above, the constructions lacking the suppressor sequences within the intron still have a propensity to be expressed in the brain, suggesting that the promoter region, or the proximal end of the intron, might contribute heightened expression in the nervous system. This would be compatible with the suggestion by Nedevi et al. (1992) based on transfection in culture, that 5' GAP-43 elements confer greater expression in neurons.
Certain neurons are capable of regenerating their axons after injury, and this is accompanied by a substantial change in a particular set ofaxonally transported growth-associated proteins (GAPS), of which GAP-43 is one (Skene and Willard, 198 1 b) . It has been suggested that this class of proteins is necessary for sequences between 4 kb and 11 kb in the first intron. Since all regenerative axonal growth. During regeneration, GAP-43 in- creases, both as axonally transported protein (Skene and Willard, 198 1 b; Skene et al., 1986) and as RNA (Hoffman, 1989) . The strong induction of /3-galactosidase in regenerating motor neurons and sensory neurons of line 150 demonstrates that its transgene includes elements responsive to the stimulus that causes regeneration. This is not to suggest that the elements causing developmental increases in GAP-43, which accompany normal axonogenesis, necessarily are identical to those that respond during regeneration, especially since the signals from the microenvironment of the developing as opposed to regenerating growth cone may be distinct.
